Byrne Asset Management’s Avidity Biosciences RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,375
Closed -$93K 580
2023
Q2
$93K Buy
+8,375
New +$93K 0.06% 200